Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950162-05-000676
Filing Date
2005-06-24
Accepted
2005-06-24 17:08:59
Documents
2
Period of Report
2005-06-22

Document Format Files

Seq Description Document Type Size
1 sigmatauform4-062405_ex.html 4  
1 sigmatauform4-062405_ex.xml 4 6684
2 JOINT FILER INFORMATION sigmatauform4-062405ex99.txt EX-99 978
  Complete submission text file 0000950162-05-000676.txt   10202
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Reporting) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 05915683

Mailing Address RUA DOS FERREIROS,260 FUNCHAL MADEIRA S1 9000-082
Business Address
DEFIANTE FARMACEUTICA LDA (Reporting) CIK: 0001168857 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 05915682